These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18076876)

  • 1. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
    Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
    Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of PU.1-induced growth inhibition and apoptosis but not differentiation block in murine erythroleukemia cells by overexpression of CBP.
    Manabe N; Yamamoto H; Yamada T; Kihara-Negishi F; Hashimoto Y; Mochizuki M; Oikawa T
    Int J Oncol; 2003 Jun; 22(6):1345-50. PubMed ID: 12739003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOOSECOID inhibits erythrocyte differentiation by competing with Rb for PU.1 binding in murine cells.
    Konishi Y; Tominaga M; Watanabe Y; Imamura F; Goldfarb A; Maki R; Blum M; De Robertis EM; Tominaga A
    Oncogene; 1999 Nov; 18(48):6795-805. PubMed ID: 10597288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells.
    Yamada T; Suzuki M; Satoh H; Kihara-Negishi F; Nakano H; Oikawa T
    Exp Cell Res; 2004 Mar; 294(1):39-50. PubMed ID: 14980499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
    Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
    Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
    Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
    Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
    Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
    Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
    Atar O; Levi BZ
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
    Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
    Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
    Yamada T; Kondoh N; Matsumoto M; Yoshida M; Maekawa A; Oikawa T
    Blood; 1997 Feb; 89(4):1383-93. PubMed ID: 9028962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
    Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
    Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional interactions between hematopoietic cell-specific ETS transcription factors and homeodomain proteins.
    Yamada T; Shimizu T; Sakurai T; Nanashima N; Kihara-Negishi F; Suzuki M; Fan Y; Akita M; Oikawa T; Tsuchida S
    Leuk Res; 2009 Mar; 33(3):483-9. PubMed ID: 18692240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ribosomal protein S5 cloned gene during differentiation and apoptosis in murine erythroleukemia (MEL) cells.
    Vizirianakis IS; Pappas IS; Gougoumas D; Tsiftsoglou AS
    Oncol Res; 1999; 11(9):409-19. PubMed ID: 10821535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a monopartite sequence in PU.1 essential for nuclear import, DNA-binding and transcription of myeloid-specific genes.
    Kwok JC; Perdomo J; Chong BH
    J Cell Biochem; 2007 Aug; 101(6):1456-74. PubMed ID: 17340619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
    Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
    Leuk Res; 2008 Jan; 32(1):121-30. PubMed ID: 17586044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes.
    Hensold JO; Barth D; Stratton CA
    J Cell Physiol; 1996 Jul; 168(1):105-13. PubMed ID: 8647904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.